▟ Vinebot intrinsic value, daily

← back

GIS General Mills

consumer_staples · valued with opus low conviction · deep-dived 2026-11-05

SELL
Intrinsic value$16.72
Price (at call)$35.85
Margin of safety -53.4%
vs market (rating basis) -43.5%

Impairments hide a still-cash-generative brand portfolio; value depends on margins recovering to about 15% despite heavy debt.

The story

General Mills is a mature packaged-food franchise (Cheerios, Pillsbury, Blue Buffalo) losing volume to private label, GLP-1 driven consumption shifts and value-seeking consumers, and it is reinvesting in price to defend share. The negative TTM operating margin reflects non-cash impairments and restructuring charges layered on a real but smaller decline in underlying profitability, not a collapse of the brands' cash generation. The company is in late maturity, and the main valuation question is where margins settle, not growth.

Growth, terminal growth, sales-to-capital, beta and failure risk are unchanged because the core story still holds: slow shrinkage, low reinvestment needs and staples-like risk. The target margin moves slightly from 15.5% to 15% because price investments have structurally reduced adjusted profitability. Margin_years moves from 2 to 3 (a material change) because the reported trough is now deeper, near -0.6% including impairments, so normalization will take longer. Net debt of about $13B makes value highly sensitive to the margin path.

Value drivers

Revenue growth (Y1)-3.0%
Terminal growth1.0%
Forecast horizon5y
Target operating margin15.0%
Years to target margin3
Sales-to-capital1.20
Beta0.65
Failure probability2.0%
Cost of capital (WACC)6.9%
Terminal WACC7.2%

Valuation bridge

PV of explicit FCFF5.24B
PV of terminal value16.98B
Equity value8.94B
÷ shares → per share$16.72

Projected free cash flow to the firm

YrRevenueGrowthMarginNOPATReinvestFCFFPV
1 17.75B -3.0% 4.6% 530.23M 0 530.23M 496.03M
2 17.39B -2.0% 9.8% 1.11B 0 1.11B 969.43M
3 17.22B -1.0% 15.0% 1.68B 0 1.68B 1.37B
4 17.22B 0.0% 15.0% 1.68B 0 1.68B 1.29B
5 17.39B 1.0% 15.0% 1.70B 143.49M 1.55B 1.11B

Key risks

  • Volume erosion from GLP-1 adoption and private label is faster than expected, so 15% margins are not recoverable
  • Further impairments signal that acquired brands (Blue Buffalo, pet treats) are worth structurally less
  • High leverage, at about $13B net debt, could pressure the dividend or the credit rating if cash flow drops

Catalysts

  • Clean quarters without impairments that show adjusted operating margin stabilizing near 15%
  • Portfolio pruning or deleveraging from divestiture proceeds

History

DatePriceIntrinsicMoSRating
2026-11-05$35.85 $16.72 -53.4% SELL
2026-09-28$33.64 $18.67 -44.5% SELL
2026-08-19$38.08 $0.00 -100.0% STRONG SELL
2026-07-09$36.33 $18.65 -48.7% SELL
2026-06-23$34.43 $26.32 -23.6% BUY